Contact this trialFirst, we need to learn more about you.
Farnesyltransferase Inhibitor
Tipifarnib for Solid Tumors
Recruiting1 awardPhase 1
Canton, Ohio
This trial tests tipifarnib on cancer patients with advanced tumors to see its effect on the heart's electrical activity, specifically the time it takes for the heart to recharge between beats. Tipifarnib has been tested in various cancer types, including advanced solid tumors and breast cancer.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service